nodes	percent_of_prediction	percent_of_DWPC	metapath
Trospium—Diphenylpyraline—SLC6A3—attention deficit hyperactivity disorder	0.0133	0.566	CrCbGaD
Trospium—Benzatropine—SLC6A3—attention deficit hyperactivity disorder	0.0102	0.434	CrCbGaD
Trospium—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00785	0.103	CbGeAlD
Trospium—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00715	0.0939	CbGeAlD
Trospium—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00664	0.0872	CbGeAlD
Trospium—CHRM3—forebrain—attention deficit hyperactivity disorder	0.0064	0.084	CbGeAlD
Trospium—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00604	0.0794	CbGeAlD
Trospium—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00426	0.056	CbGeAlD
Trospium—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.0041	0.0539	CbGeAlD
Trospium—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00388	0.051	CbGeAlD
Trospium—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00374	0.0491	CbGeAlD
Trospium—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00347	0.0456	CbGeAlD
Trospium—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00346	0.0454	CbGeAlD
Trospium—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00334	0.0439	CbGeAlD
Trospium—CHRM2—brain—attention deficit hyperactivity disorder	0.00326	0.0428	CbGeAlD
Trospium—CHRM1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00309	0.00343	CbGpPWpGaD
Trospium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00308	0.00342	CbGpPWpGaD
Trospium—CHRM3—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00308	0.00342	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00307	0.00341	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00306	0.0034	CbGpPWpGaD
Trospium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00305	0.00339	CbGpPWpGaD
Trospium—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00305	0.00339	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00303	0.00336	CbGpPWpGaD
Trospium—CHRM1—brain—attention deficit hyperactivity disorder	0.00297	0.039	CbGeAlD
Trospium—CHRM2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00276	0.00307	CbGpPWpGaD
Trospium—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0027	0.003	CbGpPWpGaD
Trospium—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00269	0.00299	CbGpPWpGaD
Trospium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00267	0.00296	CbGpPWpGaD
Trospium—CHRM1—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00266	0.00295	CbGpPWpGaD
Trospium—CHRM3—brain—attention deficit hyperactivity disorder	0.00265	0.0349	CbGeAlD
Trospium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00265	0.00294	CbGpPWpGaD
Trospium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00264	0.00293	CbGpPWpGaD
Trospium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00261	0.0029	CbGpPWpGaD
Trospium—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00257	0.00285	CbGpPWpGaD
Trospium—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00257	0.00285	CbGpPWpGaD
Trospium—CHRM3—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00245	0.00272	CbGpPWpGaD
Trospium—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00243	0.00269	CbGpPWpGaD
Trospium—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00228	0.00253	CbGpPWpGaD
Trospium—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00214	0.00238	CbGpPWpGaD
Trospium—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00213	0.00237	CbGpPWpGaD
Trospium—CHRM1—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00212	0.00236	CbGpPWpGaD
Trospium—CHRM1—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00212	0.00236	CbGpPWpGaD
Trospium—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00211	0.00235	CbGpPWpGaD
Trospium—CHRM1—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00206	0.00229	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00206	0.00228	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00205	0.00228	CbGpPWpGaD
Trospium—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00203	0.00226	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00203	0.00226	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00202	0.00224	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00201	0.00223	CbGpPWpGaD
Trospium—CHRM1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.002	0.00222	CbGpPWpGaD
Trospium—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00199	0.00221	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00199	0.00221	CbGpPWpGaD
Trospium—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00193	0.00215	CbGpPWpGaD
Trospium—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00188	0.0247	CbGeAlD
Trospium—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00187	0.00208	CbGpPWpGaD
Trospium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00187	0.00207	CbGpPWpGaD
Trospium—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00186	0.00207	CbGpPWpGaD
Trospium—CHRM1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00186	0.00207	CbGpPWpGaD
Trospium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00185	0.00205	CbGpPWpGaD
Trospium—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00183	0.00204	CbGpPWpGaD
Trospium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00183	0.00203	CbGpPWpGaD
Trospium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00181	0.00201	CbGpPWpGaD
Trospium—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00181	0.0237	CbGeAlD
Trospium—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00179	0.00199	CbGpPWpGaD
Trospium—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00177	0.0232	CbGeAlD
Trospium—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00176	0.00196	CbGpPWpGaD
Trospium—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00174	0.00193	CbGpPWpGaD
Trospium—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00174	0.00193	CbGpPWpGaD
Trospium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00173	0.00193	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00173	0.00192	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00173	0.00192	CbGpPWpGaD
Trospium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00172	0.00191	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00171	0.0019	CbGpPWpGaD
Trospium—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00168	0.00187	CbGpPWpGaD
Trospium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00168	0.00187	CbGpPWpGaD
Trospium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00166	0.00185	CbGpPWpGaD
Trospium—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00166	0.00184	CbGpPWpGaD
Trospium—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00165	0.00183	CbGpPWpGaD
Trospium—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00164	0.00182	CbGpPWpGaD
Trospium—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00163	0.00182	CbGpPWpGaD
Trospium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00163	0.00181	CbGpPWpGaD
Trospium—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00162	0.0018	CbGpPWpGaD
Trospium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00161	0.00179	CbGpPWpGaD
Trospium—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.0016	0.00178	CbGpPWpGaD
Trospium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.0016	0.00178	CbGpPWpGaD
Trospium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00158	0.00176	CbGpPWpGaD
Trospium—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00158	0.00175	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00157	0.00175	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00157	0.00174	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00155	0.00173	CbGpPWpGaD
Trospium—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00152	0.00169	CbGpPWpGaD
Trospium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00152	0.00169	CbGpPWpGaD
Trospium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.0015	0.00167	CbGpPWpGaD
Trospium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00149	0.00166	CbGpPWpGaD
Trospium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00149	0.00165	CbGpPWpGaD
Trospium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00147	0.00163	CbGpPWpGaD
Trospium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00144	0.0016	CbGpPWpGaD
Trospium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00144	0.0016	CbGpPWpGaD
Trospium—CYP2D6—brain—attention deficit hyperactivity disorder	0.00144	0.0189	CbGeAlD
Trospium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00143	0.00158	CbGpPWpGaD
Trospium—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00142	0.00158	CbGpPWpGaD
Trospium—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00141	0.00157	CbGpPWpGaD
Trospium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0014	0.00156	CbGpPWpGaD
Trospium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0014	0.00156	CbGpPWpGaD
Trospium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0014	0.00155	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0014	0.00155	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00139	0.00155	CbGpPWpGaD
Trospium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00138	0.00154	CbGpPWpGaD
Trospium—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00138	0.00153	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00138	0.00153	CbGpPWpGaD
Trospium—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00138	0.00153	CbGpPWpGaD
Trospium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00131	0.00145	CbGpPWpGaD
Trospium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0013	0.00145	CbGpPWpGaD
Trospium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00129	0.00143	CbGpPWpGaD
Trospium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00123	0.00137	CbGpPWpGaD
Trospium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00123	0.00137	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00122	0.00136	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00122	0.00135	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00121	0.00134	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00116	0.00129	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00116	0.00129	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00115	0.00127	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00114	0.00126	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00114	0.00126	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00114	0.00126	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00113	0.00126	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00112	0.00125	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00112	0.00124	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.0011	0.00122	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.0011	0.00122	CbGpPWpGaD
Trospium—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00109	0.00121	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00109	0.00121	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00108	0.0012	CbGpPWpGaD
Trospium—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00108	0.0012	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00108	0.0012	CbGpPWpGaD
Trospium—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00107	0.00119	CbGpPWpGaD
Trospium—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00107	0.00119	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00107	0.00119	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00107	0.00118	CbGpPWpGaD
Trospium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00106	0.00118	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00106	0.00118	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00106	0.00117	CbGpPWpGaD
Trospium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00105	0.00117	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00105	0.00117	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00105	0.00117	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00104	0.00116	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00103	0.00115	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00103	0.00114	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00102	0.00113	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000994	0.0011	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000991	0.0011	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000981	0.00109	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00093	0.00103	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000927	0.00103	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000918	0.00102	CbGpPWpGaD
Trospium—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000914	0.00102	CbGpPWpGaD
Trospium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000911	0.00101	CbGpPWpGaD
Trospium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000903	0.001	CbGpPWpGaD
Trospium—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000835	0.000927	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000789	0.000877	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000787	0.000874	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000779	0.000865	CbGpPWpGaD
Trospium—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000743	0.000826	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000726	0.000806	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000724	0.000804	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000717	0.000796	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000716	0.000796	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000715	0.000794	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000708	0.000786	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000696	0.000773	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000694	0.000771	CbGpPWpGaD
Trospium—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00069	0.000767	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00069	0.000766	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000688	0.000764	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000687	0.000763	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000681	0.000756	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000641	0.000712	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000639	0.00071	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000633	0.000703	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000627	0.000696	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000625	0.000694	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000624	0.000693	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000622	0.00069	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000621	0.00069	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000619	0.000688	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000619	0.000687	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000616	0.000684	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000613	0.000681	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000611	0.000679	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000611	0.000678	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000609	0.000676	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000609	0.000676	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000603	0.00067	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000603	0.00067	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000603	0.000669	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000601	0.000668	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000599	0.000665	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000597	0.000663	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000595	0.000661	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000591	0.000657	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000583	0.000647	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000581	0.000645	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000575	0.000639	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000564	0.000627	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000562	0.000625	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000562	0.000624	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00056	0.000622	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000557	0.000618	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000555	0.000616	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000555	0.000616	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000553	0.000614	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000548	0.000608	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000547	0.000608	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000546	0.000606	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000541	0.0006	CbGpPWpGaD
Trospium—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000513	0.00057	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000513	0.00057	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00051	0.000567	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000509	0.000565	CbGpPWpGaD
Trospium—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000505	0.000561	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000504	0.000559	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000469	0.000521	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000445	0.000494	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000423	0.00047	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000422	0.000469	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000418	0.000464	CbGpPWpGaD
Trospium—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00041	0.000456	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000394	0.000437	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000392	0.000436	CbGpPWpGaD
Trospium—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000391	0.000434	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000388	0.000431	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00037	0.000411	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000369	0.00041	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000365	0.000406	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000357	0.000397	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000356	0.000396	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000353	0.000392	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000344	0.000382	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000343	0.000381	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00034	0.000377	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000333	0.00037	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000332	0.000369	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000329	0.000365	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000328	0.000364	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000327	0.000363	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000324	0.000359	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000323	0.000359	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000323	0.000358	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000319	0.000355	CbGpPWpGaD
Trospium—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000311	0.000345	CbGpPWpGaD
Trospium—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000309	0.000343	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000307	0.000341	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000307	0.000341	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000302	0.000335	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000301	0.000335	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.0003	0.000334	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000298	0.00033	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000281	0.000312	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000245	0.000272	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000234	0.000259	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000211	0.000234	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00021	0.000234	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000208	0.000231	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000186	0.000206	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000185	0.000205	CbGpPWpGaD
Trospium—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000133	0.000148	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000112	0.000124	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000111	0.000124	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00011	0.000123	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	7.97e-05	8.85e-05	CbGpPWpGaD
